A challenge to chronic kidney disease in Asia: The report of the second Asian forum of chronic kidney disease initiative

Nephrology

Volumn 15, Issue 2, 2010, Pages 248-252

  Tsukamoto, Yusuke ^a   Jha, Vivekanand ^b   Becker, Gavin ^c   Chen, Hung Chun ^e   Perkovic, Vlado ^d   Prodjosudjadi, Wiguno ^f   Tungsanga, Kriang ^g   Wang, Haiyan ^h   Morad, Zaki ⁱ  

^a Shuwa General Hospital   (Japan)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

^d GEORGE INSTITUTE FOR INTERNATIONAL HEALTH   (Australia)

^e KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f UNIVERSITY OF INDONESIA   (Indonesia)

^g KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

^h PEKING UNIVERSITY   (China)

ⁱ INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

Author keywords

Asia Pacific; Chronic kidney disease; End stage renal disease; Glomerular filtration rate; International collaboration

Indexed keywords

ARTICLE; ASIA; CHRONIC GLOMERULONEPHRITIS; CHRONIC KIDNEY DISEASE; CONSENSUS DEVELOPMENT; CREATININE BLOOD LEVEL; DEVELOPED COUNTRY; DEVELOPING COUNTRY; FINANCIAL MANAGEMENT; GLOMERULUS FILTRATION RATE; HUMAN; INTERNATIONAL COOPERATION; KIDNEY FAILURE; MEDICAL SOCIETY; NEPHROLOGIST; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

ASIA; BIOLOGICAL MARKERS; CHRONIC DISEASE; COOPERATIVE BEHAVIOR; CREATININE; EVIDENCE-BASED MEDICINE; GLOMERULAR FILTRATION RATE; HUMANS; INTERNATIONAL COOPERATION; KIDNEY DISEASES; PRACTICE GUIDELINES AS TOPIC; REGISTRIES; RISK ASSESSMENT; RISK FACTORS;

EID: 77749322438     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2009.01269.x     Document Type: Article

References (31)

1. Tsukamoto Y, Wang H, Becker G et al. Report of the Asian Forum of Chronic Kidney Disease Initiative (AFCKDI) 2007. 'Current status and perspective of CKD in Asia': Diversity and specificity among Asian countries. Clin. Exp. Nephrol. 2009 13 : 249 256.
2. Levey AS, Eckardt KU, Tsukamoto Y et al. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005 67 : 2089 2100.
3. Levey AS, Greene T, Beck GJ et al. Dietary protein restriction and the progression of chronic renal disease: What have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. J. Am. Soc. Nephrol. 1999 10 : 2426 2439.
4. Zuo L, Ma YC, Zhou YH, Wang M, Xu GB, Wang HY. Application of GFR-estimating equations in Chinese patients with chronic kidney disease. Am. J. Kidney Dis. 2005 45 : 463 472.
5. Kang YS, Han KH, Han SY, Kim HK, Cha DR. Characteristics of population with normal serum creatinine impaired renal function and: The validation of a MDRD formula in a healthy general population. Clin. Nephrol. 2005 63 : 258 266.
6. Levey AS, Coresh J, Greene T et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin. Chem. 2007 53 : 766 772.
7. Imai E, Horio M, Iseki K et al. Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin. Exp. Nephrol. 2007 11 : 156 163. (Pubitemid 47012510)
8. Miller WG, Myers GL, Ashwood ER et al. Creatinine measurement: State of the art in accuracy and interlaboratory harmonization. Arch. Pathol. Lab. Med. 2005 129 : 297 304.
9. Orita Y, Okada M, Harada S, Horio M. Skim soy protein enhances GFR as much as beefsteak protein in healthy human subjects. Clin. Exp. Nephrol. 2004 8 : 103 108.
10. Nakai S, Masakane I, Akiba T et al. Overview of regular dialysis treatment in Japan (as of 31 December 2005). Ther. Apher. Dial. 2007 11 : 411 441.
11. Stewart JH, McCredie MR, Williams SM, McDonald SP. Interpreting incidence trends for treated end-stage renal disease: Implications for evaluating disease control in Australia. Nephrology (Carlton) 2004 9 : 238 246.
12. Modi GK, Jha V. The incidence of end-stage renal disease in India: A population-based study. Kidney Int. 2006 70 : 2131 2133.
13. Wang H, Zhang L, Lv J. Prevention of the progression of chronic kidney disease: Practice in China. Kidney Int. 2005 S63 S67.
14. Prodjosudjadi W. Incidence, prevalence, treatment and cost of end-stage renal disease in Indonesia. Ethn. Dis. 2006 16 : S2 S14.
15. Liu WJ, Hooi LS. Patients with end stage renal disease: A registry at Sultanah Aminah Hospital, Johor Bahru, Malaysia. Med. J. Malaysia 2007 62 : 197 200.
16. Zhang L, Zhang P, Wang F et al. Prevalence and factors associated with CKD: A population study from Beijing. Am. J. Kidney Dis. 2008 51 : 373 384.
17. Wen CP, Cheng TY, Tsai MK et al. All-cause mortality attributable to chronic kidney disease: A prospective cohort study based on 462 293 adults in Taiwan. Lancet 2008 371 : 2173 2182.
18. Collins AJ, Foley R, Herzog C et al. Excerpts from the United States Renal Data System 2007 annual data report. Am. J. Kidney Dis. 2008 51 : S1 S320.
19. Tozawa M, Iseki C, Tokashiki K et al. Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults. Hypertens. Res. 2007 30 : 937 943.
20. Shankar A, Leng C, Chia KS et al. Association between body mass index and chronic kidney disease in men and women: Population-based study of Malay adults in Singapore. Nephrol. Dial. Transplant. 2008 23 : 1910 1918.
21. Reynolds K, Gu D, Muntner P et al. Body mass index and risk of ESRD in China. Am. J. Kidney Dis. 2007 50 : 754 764.
22. Perkovic V, Cass A, Patel AA et al. High prevalence of chronic kidney disease in Thailand. Kidney Int. 2008 73 : 473 479.
23. Tsukamoto Y. End-stage renal disease (ESRD) and its treatment in Japan. Nephrol. Dial. Transplant. 2008 23 : 2447 2450.
24. Hsu CC, Hwang SJ, Wen CP et al. High prevalence and low awareness of CKD in Taiwan: A study on the relationship between serum creatinine and awareness from a nationally representative survey. Am. J. Kidney Dis. 2006 48 : 727 738.
25. Yamagata K, Iseki K, Nitta K et al. Chronic kidney disease perspectives in Japan and the importance of urinalysis screening. Clin. Exp. Nephrol. 2008 12 : 1 8.
26. Yach D, Hawkes C, Gould CL, Hofman KJ. The global burden of chronic diseases: Overcoming impediments to prevention and control. JAMA 2004 291 : 2616 2622.
27. Imai E, Yamagata K, Iseki K et al. Kidney disease screening program in Japan: History, outcome, and perspectives. Clin. J. Am. Soc. Nephrol. 2007 2 : 1360 1366.
28. Hoy WE, Kondalsamy-Chennakesavan S, Scheppingen J, Sharma S, Katz I. A chronic disease outreach program for Aboriginal communities. Kidney Int. 2005 S76 S82.
29. Collins AJ, Couser WG, Dirks JH et al. World Kidney Day: An idea whose time has come. Kidney Int. 2006 69 : 781 782.
30. Levey AS, Atkins R, Coresh J et al. Chronic kidney disease as a global public health problem: Approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007 72 : 247 259.
31. Harris D, Thomas M, Johnson D, Nicholls K, Gillin A. The CARI guidelines. Prevention of progression of kidney disease. Nephrology (Carlton) 2006 11 (Suppl 1 S2 S197.